Normal tissue dose conformality measures to guide radiotherapy fractionation decisions

Robert J. Myerson

    Research output: Contribution to journalArticlepeer-review

    9 Scopus citations

    Abstract

    Purpose: To determine conditions under which hypofractionation could be favorable for a normal tissue-even if tumor [α/β] exceeds the normal tissue's [α/β]. Methods: The hypofractionation sufficiency condition (HSC) for an organ is defined as a dose conformality constraint such that, if satisfied, a family of tumor control probability isoeffective fractionation schemes will show decreasing normal tissue complication probability with decreasing number of fractions. Results: In the extended equivalent uniform dose (EUD) model [obtained by replacing dose with linear quadratic (LQ) 2 Gy equivalent dose], the HSC for a normal organ is proven to be satisfied if a suitably weighted average of the relative dose [hypofractionation sufficiency index (HSI)] is less than the ratio of normal tissue to tumor [α/β]. The HSI is determined solely by dose distribution and the normal tissue volume factor, " a." If the HSC is satisfied for every normal tissue of concern, then there is a therapeutic gain with hypofractionation. The corresponding multifractionation sufficiency condition (therapeutic gain with increasing number of fractions) and multifractionation sufficiency index (MSI) are also derived. A sample clinical case is presented. Conclusions: Within the context of the LQ/EUD models, conformality measures (HSI and MSI) can be used to inform fractionation decisions.

    Original languageEnglish
    Pages (from-to)1799-1805
    Number of pages7
    JournalMedical physics
    Volume38
    Issue number4
    DOIs
    StatePublished - Apr 2011

    Keywords

    • biologically effective dose
    • equivalent uniform dose
    • hypofractionated radiotherapy
    • linear quadratic model
    • radiotherapy conformality measures

    Fingerprint

    Dive into the research topics of 'Normal tissue dose conformality measures to guide radiotherapy fractionation decisions'. Together they form a unique fingerprint.

    Cite this